EVA

Hybridoma cell culture supernatant containing anti-Bat influenza H17N10 antibodies; targeted antigen: NP; clone: 2E3A1; immunization antigen: recombinant NP Protein of H17N10

Hybridoma cell culture supernatant containing anti-Schmallenberg orthobunyavirus antibodies; targeted antigen: NSm; clone: 2C5C3C; immunization antigen: recombinant NSm Protein of SBV

Hybridoma cell culture supernatant containing anti-Schmallenberg orthobunyavirus antibodies; targeted antigen: Gc; clone: 5E1A3; immunization antigen: recombinant Gc Protein of SBV

Hybridoma cell culture supernatant containing anti-California encephalitis orthobunyavirus (La Crosse virus) antibodies; targeted antigen: Gc; clone: 4C12A1; immunization antigen: recombinant Gc Protein of LACV

Hybridoma cell culture supernatant containing anti-atypical pestivirus "Bungowannah" antibodies; targeted antigen: ERNS; clone: 44E2; immunization antigen: inactivated atypical pestivirus strain "Bungowannah"

Hybridoma cell culture supernatant containing anti-atypical pestivirus "Bungowannah" antibodies; targeted antigen: E1E2; clone: 30E1; immunization antigen: inactivated atypical pestivirus strain "Bungowannah"

Hybridoma cell culture supernatant containing anti-Rift valley fever virus antibody; targeted antigen: NSm; clone: 1E4C2 (IgG1); immunization antigen: recombinant NSm protein

Hybridoma cell culture supernatant containing anti-Rift valley fever virus antibody; targeted antigen: NP; clone: 22E6 (IgG1 κ); immunization antigen: recombinant N protein

Hybridoma cell culture supernatant containing anti-Rift valley fever virus antibody; targeted antigen: glykoprotein Gc; clone: 9F3 (IgG2a); immunization antigen: recombinant Gc protein

Hybridoma cell culture supernatant containing anti-Rift valley fever virus antibody; targeted antigen: glykoprotein Gn; clone: 130 (IgG2a, κ); immunization antigen: recombinant Gn protein

Hybridoma cell culture supernatant containing anti-Rift valley fever virus antibody; targeted antigen: NSm; clone: 1E9A2 (IgG2a); immunization antigen: recombinant NSm protein

Anti-Rift Valley Fever Virus; RVFV; NSs reference constisting of 6 different antibodies

VSV-IND-neutralizing antibody

This five-day course includes two modules that can be attended separately. In the first module (Ref-SKU: 011S-02851), the basic principles of routine virus typing that can be used for hospital epidemiology and public health will be addressed by a combination of lectures, demonstration and hands-on training. Participants will visit the Viroscience clinical virology lab, where they will perform all required laboratory and analysis procedures for routine typing of viruses.

This five-day course includes two modules that can be attended separately. In the first module (Ref-SKU: 011S-02851), the basic principles of routine virus typing that can be used for hospital epidemiology and public health will be addressed by a combination of lectures, demonstration and hands-on training. Participants will visit the Viroscience clinical virology lab, where they will perform all required laboratory and analysis procedures for routine typing of viruses.

Hybridoma cell culture supernatant containing anti-CCHFV antibodies; targeted antigen: glykoprotein Gn/Gc; clone: 4H12B3; immunization antigen: recombinant Gn/Gc protein, strain "IbAr 10200"

Hybridoma cell culture supernatant containing anti-SPDV antibodies; targeted antigen: unknown; clone: 15B8; immunization antigen: inactivated strain "S49P (rainbow trout)"

Hybridoma cell culture supernatant containing anti-SPDV antibodies; targeted antigen: envelope; clone: 12A5; immunization antigen: inactivated strain "S49P (rainbow trout)"

In this 3-day course the basic principles of serological testing against ARBO viruses will be addressed by a combination of lectures, demonstration and hands-on training. Participants will visit the Viroscience clinical virology lab, where they will perform all laboratory techniques including ELISA, Immunofluorescence and virus neutralization. Attention will be given to serological testing in cerebrospinal fluid, including the calculation of an antibody index.

Genomic RNAs of Lassa virus isolates AV, Togo/2016/7082, Nig-CSF, Lib06-380 and Nig08-A37 extracted from cell culture supernatant

Monoclonal antibody against LCMV nucleoprotein

In this 2-day course the basic principles of routine virus neutralization and ELISA assays will be addressed by a combination of lectures, demonstration and hands-on training. Special attention will be given to quality control and assay validation. Topics include: cell culture, biosafety procedures, preparation of sera and virus stocks, ELISA and microarray formats, different virus neutralization tests using pseudotyped viruses and wildtype viruses, immunofluorescence staining of cells, calculation of titers, assay validation and quality control.

Access to the BSL-3 facility including equipment and personal protective equipment, theoretical and practical training; preparation and evaluation of the BSL-3 work; BSL-3 virus collection as predefined within the project of the end user; personal support for performing specifically designed experiments; expert supervision.

Anti-Middle East respiratory syndrome-related coronavirus NP protein polyclonal rabbit sera

Anti-Zaire ebola virus NP protein polyclonal rabbit sera